REG - Indivior PLC - Transaction in Own Shares

IndiviorAnnouncement

05/11/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241105:nRSE8972Ka&default-theme=true

RNS Number : 8972K  Indivior PLC  05 November 2024

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

November 5, 2024

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total
of 745,703 of its ordinary shares of $0.50 each through Morgan Stanley &
Co. International Plc in the period from October 28, 2024, up to and including
November 1, 2024, in connection with its $100m Share Repurchase Program.
Aggregated information on the purchase of these shares can be found in the
table below.

Following the purchase and cancellation of the above shares (including those
purchased but not yet settled), Indivior has 127,137,848 ordinary shares of
$0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (127,137,848) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or a change
to their interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is
defined in the rules of the London Stock Exchange) and "on market" for the
purposes of the Companies Act 2006.

Aggregated information

 Trading Date  Trading Venue  Aggregated daily volume (number of shares)  Daily weighted average purchase price of the shares (p)
 28/10/2024    LSE            102,231                                     695.20
 28/10/2024    BATE           12,195                                      694.99
 28/10/2024    CHIX           50,508                                      695.39
 28/10/2024    AQUIS          2,612                                       697.11
 29/10/2024    LSE            86,326                                      699.12
 29/10/2024    BATE           26,239                                      699.90
 29/10/2024    CHIX           51,234                                      701.02
 29/10/2024    AQUIS          5,688                                       695.49
 30/10/2024    LSE            82,039                                      710.51
 30/10/2024    BATE           27,465                                      711.09
 30/10/2024    CHIX           52,927                                      712.17
 30/10/2024    AQUIS          4,640                                       710.10
 31/10/2024    LSE            80,706                                      692.74
 31/10/2024    BATE           22,887                                      690.69
 31/10/2024    CHIX           48,388                                      690.21
 31/10/2024    AQUIS          8,446                                       688.61
 01/11/2024    LSE            40,503                                      703.26
 01/11/2024    BATE           8,495                                       704.76
 01/11/2024    CHIX           26,506                                      702.91
 01/11/2024    AQUIS          5,668                                       700.72

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation
(EU) No 596/2014, as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary shares
made by Morgan Stanley & Co. International Plc on behalf of Indivior
during the above period as part of the Share Repurchase Program can be found
at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program
(http://www.indivior.com/en/investors/shareholder-information/share-repurchase-program)
.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSFZMGMGDDGDZZ